摘要:
A seat belt tensioning device comprises a cylinder, a piston which is slidably inserted within the cylinder, a rod which connects the piston and the seat belt, a piston pushing means which is provided within the cylinder for applying driving force to the piston, a trigger means which comprises a plurality of rings and balls interposed between opposed rings and which is provided in the cylinder for usually locking the rod into the cylinder overcoming the driving force of the piston pushing means and releasing the rod from the cylinder to allow the movement of the piston only at an urgent time, and a driving means for driving the trigger means to release the rod from the cylinder at an urgent time.
摘要:
A fusible plug employs an alloy which comprises 5-8 mass % of Sn, 31-34 mass % of Bi, 0.2-4 mass % of Sb, and a remainder of In. The alloy melts at approximately 66-70° C. The alloy may further contain at most 2.0 mass % of at least one element selected from strengthening elements consisting of 0.1-1.0 mass % of Cu, 0.1-1.0 mass % of Ge, 0.1-0.7 mass % of Ag, 0.1-0.6 mass % of Au, 0.2-0.6 mass % of Zn, 0.002-0.1 mass % of Ni, and 0.01-0.1 mass % of a lanthanoid.
摘要:
The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication.
摘要:
The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder.
摘要:
The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1): wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.
摘要:
The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1): wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.
摘要:
A sprinkler head adapted for a specific yield temperature. The sprinkler head uses a heat-sensitive material composed of Sn in an amount of 0.1-2.0% by mass, Bi in an amount of 31-37% by mass and In for balance for a temperature range around 70-75° C. or a heat-sensitive material composed of Zn in an amount of 0.05-0.4% by mass, Bi in an amount of 43-55% by mass and In for balance for a temperature range around 90-95° C.
摘要:
The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.
摘要:
A fuel cell control system is provided which is designed to ensure the stability of operation of a fuel cell stack. The system includes a magnetic sensor and a controller. The magnetic sensor works to measure a change in magnetic flux density of magnetic field produced by an electric current as generated by electrochemical reaction taken place in each of fuel cells. The controller is designed to analyze the change in magnetic flux density measured by the magnetic sensor to specify the cause and location resulting in a drop in ability of the fuel cell stack to generate electricity which is to occur partially in the fuel cell stack. The controller takes a predetermined measure to control the operation of the fuel cell stack for eliminating the drop in ability of the fuel cell stack to generate the electricity.
摘要:
The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.